Centrafarm Services B.V.
PolandAll drugs from this manufacturer
-
This medicine is used to treat patients with essential thrombocythemia. It helps to reduce the production of platelets by the bone marrow, bringing their number down to a more normal level.
Dosage form: capsules, hard
Active substance Dosage anagrelide 0.5 mg ATC: L01XX35
-
The medicine is intended for the treatment of severe chronic pain in adults who require opioid analgesic treatment.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol phosphate 38.285 mg ATC: N02AX06
-
BINATTA is intended for the treatment of severe chronic pain in adults for whom opioid analgesic treatment is necessary.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol phosphate 76.57 mg ATC: N02AX06
-
It is used in the treatment of severe chronic pain in adults for whom opioid medication is necessary.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol phosphate 153.139 mg ATC: N02AX06
-
The medicine is intended for the treatment of severe chronic pain in adults for whom the use of opioid medicines is necessary for proper treatment.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol phosphate 229.709 mg ATC: N02AX06
-
The medicine is used for the treatment of severe chronic pain in adults who require opioid analgesic treatment.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol phosphate 306.279 mg ATC: N02AX06
-
The medicine is intended for the treatment of severe chronic pain in adults for whom opioid medication is necessary.
Dosage form: tablets, prolonged release
Active substance Dosage tapentadol phosphate 382.848 mg ATC: N02AX06
-
The medicine is used for the short-term relief of sore throat symptoms, such as pain, irritation, swelling, and difficulty swallowing.
Dosage form: tablets, hard
Active substance Dosage flurbiprofen 8.75 mg ATC: R02AX01
-
The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (in patients for whom other medicines have not worked) and in adults with hepatitis C virus infection who have difficulties due to a low platelet count during interferon treatment.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 25 mg ATC: B02BX05
-
The medicine is used to increase the number of platelets in the blood. It is intended for the treatment of immune thrombocytopenia (primary) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 50 mg ATC: B02BX05
-
The medicine is used to increase the number of blood platelets. It is intended for the treatment of immune thrombocytopenia (primary) in individuals over 1 year of age for whom other medicines have not worked, and in adults with hepatitis C virus infection who have a low platelet count.
Dosage form: tablets, film-coated
Active substance Dosage eltrombopag 75 mg ATC: B02BX05
-
The medicine is used in adults and children and adolescents (over 10 years of age with a body weight over 40 kg) for the treatment of relapsing-remitting multiple sclerosis (MS), especially in individuals for whom treatment is ineffective or in patients with a rapidly progressing, severe form of the disease. It helps to reduce the number of relapses and slow the progression of disability.
Dosage form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0.56 mg ATC: L04AE01
-
The medicine is used for the short-term relief of mild to moderate pain, such as headache, toothache, menstrual pain, as well as fever and pain associated with the common cold.
Dosage form: capsules, soft gelatin
Active substance Dosage ibuprofen 400 mg ATC: M01AE01
-
This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults and in children over 18 years of age weighing at least 40 kg. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers blood pressure, and reduces disease symptoms such as fatigue or shortness of breath.
Dosage form: tablets, film-coated
Active substance Dosage macitentan 10 mg ATC: C02KX04
-
The medicine is used to treat mild to moderate idiopathic pulmonary fibrosis in adults. It helps to reduce lung swelling and scarring, which makes breathing easier.
Dosage form: tablets, film-coated
Active substance Dosage pirfenidone 267 mg ATC: L04AX05
-
The medicine is used to treat mild to moderate idiopathic pulmonary fibrosis in adults. It helps to reduce lung swelling and scarring, which makes breathing easier.
Dosage form: tablets, film-coated
Active substance Dosage pirfenidone 534 mg ATC: L04AX05
-
The medicine is used to treat mild to moderate idiopathic pulmonary fibrosis in adults. It helps to reduce lung swelling and scarring, which makes breathing easier.
Dosage form: tablets, film-coated
Active substance Dosage pirfenidone 801 mg ATC: L04AX05
-
This medicine is used to treat the symptoms of an overactive bladder. It helps to reduce the sudden urge to urinate, decreases the frequency of toilet visits, and allows for a greater capacity to hold urine in the bladder.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin succinate 5 mg ATC: G04BD08
-
This medicine is used to treat the symptoms of an overactive bladder. It helps to reduce the sudden urge to urinate, decreases the frequency of toilet visits, and allows for a greater capacity to hold urine in the bladder.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin succinate 10 mg ATC: G04BD08
-
Valcyclox is used to treat CMV retinitis in adults with AIDS and to prevent CMV infections in adults and children who have received an organ transplant from donors infected with this virus.
Dosage form: tablets, film-coated
Active substance Dosage valganciclovir 450 mg ATC: J05AB14